A LEAP of Faith
June 28, 2022
Two friends, two countries; one disease, one network to fight it
6 min read
June 2022
Join us in a journey across the global south, as we take a look at a selection of open science projects run by the Drugs for Neglected Diseases initiative. From there, look to the future as we ask the experts: can AI reshape pharma forever? Also in the issue, an interview with a Kyiv-based CRO weathering Russian invasion, the story behind a Euro-African vaccine manufacturing initiative, and the strange case of Sanofi’s ASMR foray into Soundcloud…
Words With the Fearless Leader
June 22, 2022
Where did DNDi come from – and where is it going?
6 min read
Changing People’s Perspectives
June 22, 2022
Sitting Down With… Akhil Ravi, CEO of Aurigene Pharmaceutical Services, a Dr. Reddy’s Laboratories company, India
6 min read
Clinical Trials: Getting Smart with Pill Dispensing
June 2, 2022
Is it possible to improve clinical trials with smart packaging and devices?
6 min read
Towards Better Biosimilar Access
May 25, 2022
Offering originator alternatives sounds great on paper – but how what about in practice?
4 min read
Kyiv: Escape and Return
May 10, 2022
Ukraine is proving to be a crisis-resistant country – and Kyiv-based drug discovery CRO Enamine is finding itself just as resilient
1 min read
Champions of Cell and Gene Therapy
April 26, 2022
How could the spotlight on mRNA impact the cell and gene field?
1 min read
The Final Frontier for Regenerative Medicine
April 25, 2022
What will drug development look like aboard a new commercial space station?
1 min read
A Tale of Two Continents
April 13, 2022
How discussions between the European and African Unions have culminated in a new deal for African vaccine production
1 min read
The Early Bird Gets the…
April 4, 2022
All decisions have a ripple effect throughout your cell sourcing supply chain; you must adopt a commercial mentality right from the start
1 min read
